BIONEXT

BioNext is a French biotechnology company dedicated to the better understanding and treatment of various diseases. BIONEXT aims to accelerate and improve the effectiveness of drug development and biological research by developping programs and software-based tools to tackle problematics of prime importance in the pharmaceutical field, such as drug profile assesment or suggestion of drug repurposing.
BIONEXT
Industry:
Biotechnology Life Science
Founded:
2009-01-01
Address:
Strasbourg, Alsace, France
Country:
France
Website Url:
http://www.bionext.com
Total Employee:
11+
Status:
Active
Contact:
+33 1 46 10 98 00
Email Addresses:
[email protected]
Total Funding:
1000 K EUR
Technology used in webpage:
SPF Mobile Non Scaleable Content Euro Amazon PHP Apple Mobile Web App Capable Amazon Virginia Region Java EE Unix NameBright
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alsace Business Angels
Alsace Business Angels investment in Seed Round - BioNext
Cap Innov'Est
Cap Innov'Est investment in Seed Round - BioNext
Official Site Inspections
http://www.bionext.com
- Host name: 199.59.243.228
- IP address: 199.59.243.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "BioNext"
bioNEXT - Canada's Bioeconomy Network - Foresight
BioNEXT is a sector-specific, ecosystem-based accelerator established by Foresight to drive development and scaling of Canadian ventures in the bioeconomy.See details»
BioNext
Vision: A Collaborative Hub (Physical Space) to drive commercialization of life science innovation and build MedTech entrepreneurs.; Mission: To create an ecosystem that attracts investment โฆSee details»
Bionexo - Crunchbase Company Profile & Funding
Bionexo is a Brazilian health tech company that offers digital solutions for managing healthcare processes. Through an ecosystem of digital solutions, Bionexo automates processes, bringing โฆSee details»
BioNext - LinkedIn
BioNext | 164 followers on LinkedIn. BioNext is Western's MedTech incubator created to foster the translation of innovative ideas to commercial products. | BioNext, Western Universityโs Medical โฆSee details»
Bionexo Company Profile 2024: Valuation, Funding & Investors
Bionexo General Information Description. Developer of a technology software intended to offer digital services for managing healthcare processes. The company provides an integrated suite โฆSee details»
Bionext Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Bionext. Use the PitchBook Platform to explore the full profile.See details»
Bionexo - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead ... Unlock for free . Dec 14, 2018: Private โฆSee details»
BioNext - Crunchbase Company Profile & Funding
BioNext is a French biotechnology company dedicated to the better understanding and treatment of various diseases. BIONEXT aims to accelerate and improve the effectiveness of drug โฆSee details»
Bionexo - Bain Capital Tech Opportunities
Founded in 2000 in São Paulo, Bionexo provides an integrated suite of cloud software and marketplace technology tools to help hospitals efficiently source critical care products while โฆSee details»
Bionexo - Overview, News & Similar companies | ZoomInfo.com
Bionexo has announced that Temasek has acquired a minority stake in the organization. Mergers & Acquisitions. See more scoops. ... Founded in 2000, Bionexo is a technology company that โฆSee details»
Bionexo - Products, Competitors, Financials, Employees, โฆ
Headquarters Location. Avenue Juscelino Kubitscheck 1830, Brooklin Novo. Sao Paulo, 04571-000, Brazil. 55 (11)3133-8100See details»
Bionexo.com - Craft
Bionexo.com $104.05 m in total funding,. See insights on Bionexo.com including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Driving Innovation: BioNext MedTech Incubator Spearheads ...
Jul 24, 2023 BioNext, as Western University's MedTech Incubator, is driving medical technology innovation and facilitating the commercialization of groundbreaking concepts. Its primary focus โฆSee details»
Home | Bionexo
Líder de mercado, a Bionexo oferece soluções digitais que permitem que fornecedores e compradores interajam de forma fácil, rápida e inteligente. Uma empresa de tecnologia SaaS โฆSee details»
Home - Bionexo
Pionera y líder del mercado, Bionexo posee soluciones digitales que permiten que compradores y vendedores interactúen de forma fácil, rápida e inteligente. De la planificación del stock y de la โฆSee details»
Structuring a better organization model | by Lucas Colucci
Oct 29, 2018 The first turned every company, even if it was a centenary one, into a tech organization. Everyone needs an Agile Coach now. Especially after the advent of the Spotify โฆSee details»
Explore Canada's Bioeconomy Ecosystem Map - bioNEXT - Foresight
141 companies were assigned to Canadaโs forest bioeconomy value chain and are highly concentrated in Canadaโs four largest provinces. The map is a living resource that is regularly โฆSee details»
Bionext completes test programme - Hydrocarbon Engineering
Aug 4, 2021 Bionext and its partners have successfully completed the test programme on BioTfueL ® demonstration units, a crucial step in the development of this technology that will โฆSee details»
BioNeex - Crunchbase Company Profile & Funding
BioNeex is a biopharma R&D open exchange platform and two-sided marketplace that directly connects biotech and biopharmaceutical.See details»
Login - Bionexo
Nov 21, 2024 Bionexo do Brasil - todos os direitos reservados Versão: 6.77.0-SNAPSHOT - November 21 2024 18:28See details»